Cancer prevention policy in the EU:

Slides:



Advertisements
Similar presentations
Health in Prisons Project Establishing a Monitoring Mechanism on Prison Health Indicators and Health Determinants Working Party on Information on Lifestyle.
Advertisements

Capacity Building for Public Health and Health Promotion in Central and Eastern Europe Caroline Costongs Programme Manager EuroHealthNet
NCCP WHO 1995 Regional tumour registry, Lund October 1995 Primary prevention - tobacco Education Schoolchildren from age 10 years Promote peer-to-peer.
FROM EUROCHIP-1 TO EUROCHIP-2 EUROCHIP-2 - The action Public Health Program EUROPEAN COMMISSION: HEALTH & CONSUMER PROTECTION DIRECTORATE-GENERAL.
Improving Cancer Outcomes at a national level - The story from England Professor Sir Mike Richards National Cancer Director June
European Partnership for Action Against Cancer (EPAAC)
EUROCHIP-2 the action Health Indicators for Monitoring Cancer in Europe Public Health Program EUROPEAN.
Women’s Heart Policy October, 2004 Gastein John O’Toole (personal capacity) Perm Rep of Irl to EU.
Public Health Perspective on Radon Control in Ireland Dr. Ina Kelly Specialist Registrar in Public Health Medicine Health Service Executive Department.
Policy recommendations for wider implementation of telemedicine Peeter Ross, MD, PhD e-Health expert, Estonian eHealth Foundation, Estonia.
Can the Concept of Avoidable Deaths Complement WHO Health System Performance? Elena A. Varavikova, MD, PhD, MPH, Researcher, OSD/FSP.
Cancer Prevention in Taiwan
Cancer Program Fewer Montanans experience late stage cancer. Fewer Montanans die of cancer. Metrics Biannual percent of Montanans who are up-to-date with.
Departmental Perspectives on Viral Hepatitis
1 EUROPA DONNA – The European Breast Cancer Coalition Susan Knox, Executive Director KEEPING BREAST CANCER ON THE EUROPEAN HEALTH AGENDA.
HOW TO CONTROL CANCER Putting Science into Practice.
Kenya Field Epidemiology and Laboratory Training Program (KFELTP)
ADAMOS ADAMOU, MEDICAL ONCOLOGIST MEMBER OF THE EUROPEAN PARLIAMENT.
NOT ALL PAST SUCCESSES IN CANCER RESEARCH HAVE BEEN FOLLOWED BY ACTIONS EUROCHIP-2 THE ACTION Project & news EUROCHIP-2 THE ACTION Project & news Public.
THANK YOU!. Regional Adviser, Noncommunicable Diseases, WHO/EMRO Dr Ibtihal Fadhil.
Cancer Incidence and Mortality in Massachusetts, Bureau of Health Statistics, Research and Evaluation Massachusetts Department of Public Health.
Kathrin Strasser-Weippl 1 st Medical Department Wilhelminen Hospital, Vienna Cancer Care in Europe.
Statistics about unknown primary tumors Riccardo Capocaccia National Centre for Epidemiology, Surveillance and Health Promotion Istituto Superiore di Sanità,
Grace and Alanah. National Health Priority Areas. Cancer.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System HIV in the United Kingdom: 2012 Overview.
Population Mortality and Morbidity in Ireland n April 2001.
National Perspective Cancer Early Detection & Prevention Performance Review Event October 2008 National Cancer Action Team Kathy Elliott National Lead.
European Union against cancer The EUROCHIP project 1st International Cancer Control Congress Vancouver, October 2005 Public Health Program EUROPEAN.
CANCER CONTROL NHPA’s. What is it? Cancer is a term to describe a diverse group of diseases in which some of the cells in body become defective. The following.
Chester Ellesmere Port & Neston Rural Making sure you get the healthcare you need West Cheshire CCG Strategy Dr Andy McAlavey Medical Director West Cheshire.
Algeria Croatia EgyptFranceGreece ItalyJordanLebanonLybiaMorocco PortugalSyriaSloveniaSpainTunisiaTurkeyPalestine Albania Cyprus MacedoniaMalta Mediterranean.
Cancer Mortality Target Measuring and Monitoring at a National Level Jennifer Benjamin, Department of Health Kathy Elliott, National Cancer Action Team.
HTA Benefits and Risks Dr Bernard Merkel European Commission.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
The ERA-NET TRANSCAN-2, in continuity with the preceding ERA-NET TRANSCAN, aims at linking translational cancer research funding programmes in 15 Member.
2014 HIV/AIDS Surveillance in the European Union and European Economic Area (EU/EEA) European Centre for Disease Prevention and Control, Stockholm WHO.
Improving Cancer Outcomes in Camden Dr Lucia Grun 19 March 2014.
1 CHRONIC CONDITION SELF-MANAGEMENT FLINDERS HUMAN BEHAVIOUR & HEALTH RESEARCH UNIT THE FLINDERS MODEL.
M O N T E N E G R O Negotiating Team for the Accession of Montenegro to the European Union Working Group for Chapter 28 – Consumer and Health Protection.
1 Study on the Coverage of Chronic Diseases in Social and Health Protection Systems: A Comparative Analysis of Trends in Developed Countries and in the.
Findings on how the legal system addresses multiple discrimination in healthcare Erica Howard, Senior Lecturer in Law, Middlesex University.
Anne-Marie Yazbeck, PhD National Infoday, Sweden 2017
Cancer prevention and early detection
NCD in Bulgaria Assoc. Prof. Plamen Dimitrov, MD, PhD
World Health Organization
World Health Organization
prevention and control of non communicable diseases in Iraq
Musculoskeletal Health in Europe
Jane E Scullion Respiratory Nurse Consultant
Trends in the UK Annual Alcohol Consumption per UK Resident
GARD/NCD Action Plan & 2011 UN Summit on NCDs
Definition of Cancer Screening
Dr James Carlton, Medical Adviser
Methodology for the assessment of Member States’ reporting on Programme of Measures (Article 16) MSCG Sarine Barsoumian 7 April /09/2018.
HEALTH PROFESSIONAL ENGAGEMENT PROGRAMME:
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
Lung Cancer in Lewisham
HIV/AIDS Surveillance in Europe 2011
Gonorrhoea cases of gonorrhoea were reported by 27 EU/EEA Member States for The overall notification rate was 18.8 cases per 100 000 population.
Tit Albreht | Brussels | 7 November 2017
EU: First- & Second-Generation Immigrants
Niek Klazinga, Trnava, Thursday
the European Qualifications Framework (EQF)
State of play of OP negotiations
Monitoring progress in the field of education and training
National Cancer Center
WP 10 National Cancer Plans Prepared by:
Dr Timothy Armstrong Coordinator
Includes data from the Welsh Cancer Intelligence and Surveillance Unit
Presentation transcript:

Cancer prevention policy in the EU: Best practices are now well recognised; no reason for countries to lag behind Carolina Espina, PhD, MPH.

background Cancer is a major public health problem in the EU About 3 mill new cancer cases in 2018 (1.7 mill cases in men and 1.5 mill in women) Over 1.4 mill cancer deaths (800,000 in men and 600,000 in women) --> 26% all deaths Most common: prostate, lung and colorectal cancers in men; and breast, colorectal and lung in women Around 40% cancer cases can be prevented through practices and actions targeted towards risk prevention at the individual and population levels Prevention offers the most cost-effective long-term strategy for the control of cancer The European Code against Cancer stands out among other initiatives for its clarity and accessibility as a short set of recommendations for the general public It also acts as a guide to aid development of national health policies in cancer prevention and provides an important basis for health promotion

Large regional differences in cancer burden within Europe Estimated age-standardised cancer mortality rate in Europe in 2018, by country, both sexes, all sites but non-melanoma skin, all ages Large regional differences in cancer burden within Europe Wide international heterogeneity in the extent to which cancer control structures had been implemented in Europe

National Cancer Control Programme National Cancer Control Programme (NCCP) is a public health programme that, by implementing systematic, equitable and evidence-based strategies for prevention, early detection, diagnosis, treatment and palliation, will reduce the number of cancer cases and deaths and improve quality of life of cancer patients [WHO 2002] NCCP offers the most rational means of achieving a substantial degree of cancer control, even where resources are severely limited, by identifying and implementing priorities for action and research Most NCCPs, Plans or Strategies include as main elements: primary prevention (health promotion and environmental protection), secondary prevention (screening and early detection), integrated care and organization of services, and palliative care Research, training and quality control elements are also frequently mentioned

Searched for the most recent and comprehensive NCCPs in: Definitions of programme, plan and strategy varies among countries (plan and programme are often interchangeably) --> NCCPs = all programs, plans or strategies Searched for the most recent and comprehensive NCCPs in: International Cancer Control Partnership (ICCP) European Partnership for Action Against Cancer (EPAAC) and the Cancer Control (CanCon) Joint Actions With EPAAC, EC called upon the Member States to set up National Cancer Plans or Strategies by the end of 2013 2 surveys performed to inform EU policymakers about the extent to which this goal has been achieved WHO Non-communicable Disease Document Repository Analysis published in 2009 based on 19 publicly available NCCPs (12 of the countries studied had yet to formulate NCCPs) No internationally agreed format for a NCCP nor any commonly accepted framework for analysis of their impact

RESULTS For all the 28 EU countries, at least one of the most recent documents was identified except for Bulgaria, Croatia and the Slovak Republic 8 countries have NCCPs; 11 countries have Cancer Control Plans; 6 countries have Cancer Control Strategies Cyprus has a Strategy as well as an Action Plan; UK: Northern Ireland has a NCCP, Scotland and Wales have a Cancer Control Plan, and England has a Cancer Control Strategy Romania has announced in 2016 the launch of an Integrated Multi-Annual National Cancer Control Plan for 2016–2020 (document not found by the authors) Different timelines and number of editions of NCCPs Denmark, England, France and Malta are acting on the basis of a 3rd or 4th NCCP

The ECAC offers an exceptional public health tool to support governments to inform policy formulation, in the implementation of their cancer control strategies and policies, as well as feeds into public awareness campaigns on cancer prevention Malta and Slovenia have recently launched their comprehensive National Cancer Plans for 2017–2021 following the structure proposed by the ECAC, stressing preventive actions to reduce the increasing number of cancer burden in the country Spain, Poland, Cyprus, Hungary and Ireland also mention the ECAC in their NCCPs

Little research comparing the effect of national preventive policies on cancer incidence and mortality Evaluations focused on very specific interventions, such as tobacco control or screening Only 2 quantitative studies on the direct impact of NCCPs on national cancer burden found England: little evidence of direct impact of the effectiveness of the 2000 NHS Cancer Plan and related national cancer policy initiatives, on one year cancer survival France: 2003–2007 Cancer Plan included behavioural changes & environmental risk factors; additional objectives (e.g. sedentary lifestyle, prevention of infections)  none of these objectives can be considered achieved (evaluation report)

Mackenbach et al. 2013: compared quantitatively the performance of 43 European countries in 11 areas of health policy (including some cancer policies) Substantial differences between implementation and intermediate and final health outcome (e.g. tobacco and alcohol control) Wealthier countries had higher levels of fruit and vegetable consumption, but also a higher proportion of fat in their diets Higher mortality from cervical and breast cancer in countries without a population-based screening programme (in comparison to neighbouring countries) Gaps in information about policies implementation and intermediate and final health impact  Existing comparative analyses of health policies mostly based on policymakers’ reports

conclusions Prevention offers the greatest public health potential and the most cost- effective long-term cancer control strategy Still important differences in health in the EU (i.e. cancer incidence and mortality) partly due to deficits in the implementation of best practices Need to formulate sustainable, effective and responsive policies for patients and citizens Effective and efficient NCCP implementation needs competent management in: planning: to identify priorities and resources implementation, monitoring and evaluation: to organize and coordinate those resources to guarantee sustained progress to meet the planned objectives

+ the population health impact No simple relationship between adoption or implementation of a plan and beneficial public health outcomes Despite Denmark, UK, France or the Netherlands being earliest adopters of comprehensive plans, they have incidence and mortality above the EU average Time-lag: effective implementation  behavioural change impact on outcome The lack of an accepted framework to aid formulation of NCCPs + scare evidence on policies effectiveness Hamper the analyses of the degree of implementation of policies + the population health impact The ECAC provides a solid backbone, based on evidence, for supporting NCCPs by giving two clear messages (1) cancers can be avoided (2) cancers can be cured

THANK YOU! go raibh maith agat